1159598-35-2 Usage
Uses
Used in Pharmaceutical and Agrochemical Industries:
(R)-4-Methyl-2-(hydroxyMethyl)Morpholine is used as a building block in the synthesis of pharmaceuticals and agrochemicals for its ability to contribute to the development of new and effective compounds.
Used in Organic and Medicinal Chemistry:
(R)-4-Methyl-2-(hydroxyMethyl)Morpholine is utilized as a reagent in organic and medicinal chemistry, facilitating various chemical reactions and processes.
Used in Solvent Applications:
(R)-4-Methyl-2-(hydroxyMethyl)Morpholine is used as a solvent for cellulose derivatives, resins, and dyes, due to its ability to dissolve a wide range of substances.
Used in Corrosion Inhibition:
(R)-4-Methyl-2-(hydroxyMethyl)Morpholine is employed as a corrosion inhibitor for metals, protecting them from degradation and extending their lifespan.
Used in Cleaning Products:
(R)-4-Methyl-2-(hydroxyMethyl)Morpholine is a component of some cleaning products, contributing to their effectiveness in removing dirt and stains.
Used in Emulsion and Dispersion Stabilization:
(R)-4-Methyl-2-(hydroxyMethyl)Morpholine is used as a stabilizer for emulsions and dispersions, ensuring their stability and preventing separation.
Check Digit Verification of cas no
The CAS Registry Mumber 1159598-35-2 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,1,5,9,5,9 and 8 respectively; the second part has 2 digits, 3 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 1159598-35:
(9*1)+(8*1)+(7*5)+(6*9)+(5*5)+(4*9)+(3*8)+(2*3)+(1*5)=202
202 % 10 = 2
So 1159598-35-2 is a valid CAS Registry Number.
1159598-35-2Relevant academic research and scientific papers
RAS INHIBITORS AND METHODS OF USING THE SAME
-
Paragraph 000150, (2021/08/06)
Provided herein are compounds identified as inhibitors of KRAS protein activity that can be used to treat various diseases and disorders, such as cancer.
COVALENT INHIBITORS OF KRAS
-
Page/Page column 196-197, (2018/12/13)
Compounds having activity as inhibitors of G12C mutant KRAS protein are provided. The compounds have the following structure (I): or a pharmaceutically acceptable salt, stereoisomer, isotopic form or prodrug thereof, wherein R1, R2a,
PIPERAZINES AS ANTI-OBESITY AGENTS
-
Page/Page column 32, (2009/07/17)
The present invention relates to new compounds of formula (I), to pharmaceutical compositions comprising these compounds, to processes for their preparation, and to the use of these compounds as leptin receptor modulator mimetics in the preparation of medicaments against conditions associated with weight gain, type 2 diabetes and dyslipidemias.
